Charter Life Sciences is a private equity general partner firm located in United States.
Third point along with existing investors led a $25m Series C round for Xlumena, a developer of advanced endoscopic devices.
DCP led a $20m Series B round for Amaranth Medical, with participation from Bio*One Capital, Charter Life Sciences and Venstar Capital.
GSR Ventures led a $7m Series A round for women's healthcare company Mirabilis Medica, with participation from Charter Life Sciences.
Read more news concerning Charter Life Sciences
A sampling of Charter Life Sciences portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?